OncoPharm cover image

Tale from the Crypt: Belantamab Mafodotin

OncoPharm

00:00

DREAM7 design: combination versus daratumumab

John Bizarro outlines DREAM7 comparing belantamab plus bortezomib-dex to daratumumab with bortezomib-dex and key dosing differences.

Play episode from 03:11
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app